Boeckh-Behrens, Tobias http://orcid.org/0000-0003-0266-8947
Golkowski, Daniel
Ikenberg, Benno
Schlegel, Jürgen
Protzer, Ulrike
Schulz, Christian
Novotny, Julia
Kreiser, Kornelia
Zimmer, Claus
Hemmer, Bernhard
Wunderlich, Silke
Funding for this research was provided by:
Projekt DEAL
Article History
Received: 11 November 2020
Accepted: 28 December 2020
First Online: 29 January 2021
Conflict of interest
: C. Zimmer disclosed no relevant relationships regarding activities related to the present article. He has served on scientific advisory boards for Philips and Bayer Schering; serves as co-editor on the Advisory Board of Clinical Neuroradiology; has received speaker honoraria from Bayer-Schering and Philips; the institution has received research support and investigator fees for clinical studies from Biogen Idec, Quintiles, MSD Sharp & Dome, Boehringer Ingelheim, Inventive Health Clinical UK Ltd., Advance Cor, Brainsgate, Pfizer, Bayer-Schering, Novartis, Roche, Servier, Penumbra, WCT GmbH, Syngis, SSS International Clinical Research, PPD Germany GmbH, Worldwide Clinical Trials Ltd., Phenox, Covidien, Actelion, Medivation, Medtronic, Harrison Clinical Research, Concentric, Pharmtrace, Reverse Medical Corp., Premier Research Germany Ltd., Surpass Medical Ltd., GlaxoSmithKline, AXON Neuroscience, Bristol-Myers Squibb, Genentech, Acandis, EISAI, NeuroRx, Italfarmaco, Bioclinica, MIAC and IXICO. No patents issued and pending. B. Hemmer reports personal fees from Desitin, Novartis, Allergy Care and TG Therapeutics outside the submitted work. T. Boeckh-Behrens, D. Golkowski, B. Ikenberg, S. Jürgen, U. Protzer, C. Schulz, J. Novotny, K. Kreiser and S. Wunderlich declare that they have no competing interests.